CUR has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China. Read more…
Proposed trial to use Retinal Pigment Epithelial Cells derived from Embryonic Stem Cells to treat Stargardt’s Macular Dystrophy. Read more…
This prospectus (filed 4/18/11) relates to the disposition of up to 21.5M shares of common and 10,460,875 warrants, Read more…
Regenerative medicine/stem cell universe stocks were down since the day started on Monday (4/18/11). Read more…
STEM entered into collaboration with Frank LaFerla, PhD, Read more…
Shares of regenerative medicine companies gyrated through Friday, 4/15/11, after being pushed up and down during the week. Read more…
Japanese medical experts are advising blood be taken from workers at nuclear plant(s) to prepare for possible future stem cell transplants Read more…
IMUC.OB presented safety and preliminary efficacy data of the PI dendritic cell cancer clinical trial Read more…
OPXA presented clinical data highlighting efficacy data from OPXA’s Phase IIb TERMS clinical trial in a sub-population of patients Read more…
RENE.L’s human neural stem cell lines show for the first time, a clinically relevant model how anti-depressant drugs make new brain cells. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.